ABOS
#3601
Acumen Pharmaceuticals, Inc. - Common Stock
2.8 5 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.40%
Monthly Change
+31.34%
6 month change
-8.65%
Year Change
+111.11%
Previous Close
2.9 2
Open
2.8 5
Low
2.8 5
High
2.8 5
Volume
49
Financials
- Market Capitalization 206.1 M
- Employee 61
- Founded 1996
- CEO N/A
- Website www.acumenpharm.com
- Headquarter Delaware, United States
- FIGI BBG0058YJ317
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.65
Price to sales ratio
808.5
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3595 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.58 USD | +1.98% | +6.17% | +8.40% | -11.64% | 207.87 M USD | ||
| 3597 |  PEPG PepGen Inc. - Common Stock | 2.99 USD | -2.92% | -6.27% | +68.93% | +155.56% | 207.09 M USD | ||
| 3611 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 5.47 USD | +3.21% | 0.00% | +20.22% | -33.07% | 203.39 M USD | ||
| 3612 |  IPHA Innate Pharma S.A. - American Depositary Shares | 2.17 USD | -2.69% | -2.25% | +24.00% | +4.33% | 203.37 M USD |
Frequently asked questions about Acumen Pharmaceuticals, Inc. Common Stock
What is the Acumen Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) is 2.85. Over the past 24 hours, the stock has changed by -2.40%. Follow the ABOS chart for real-time price dynamics.
What is the stock ticker of Acumen Pharmaceuticals, Inc. Common Stock?
Acumen Pharmaceuticals, Inc. Common Stock trades under the ticker ABOS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Acumen Pharmaceuticals, Inc. Common Stock stock going up?
ABOS has changed by -7.77% over the last week, +31.34% over the last month, and +111.11% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Acumen Pharmaceuticals, Inc. Common Stock?
Acumen Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 206.1 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Acumen Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Acumen Pharmaceuticals, Inc. Common Stock reported earnings of -0.45 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Acumen Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Acumen Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Acumen Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Acumen Pharmaceuticals, Inc. Common Stock reported net income of -32.72 M for the last quarter. The previous quarter showed -20.74 M, which means net income changed by -57.78%.
How many employees does Acumen Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Acumen Pharmaceuticals, Inc. Common Stock has 61 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Acumen Pharmaceuticals, Inc. Common Stock stock?
You can buy Acumen Pharmaceuticals, Inc. Common Stock (ABOS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Acumen Pharmaceuticals, Inc. Common Stock stock?
Investing in Acumen Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABOS chart and related analysis on metatrader.com as part of your research.